CrushSCI.com
Journal Selection & Manuscript Polishing Services
Purinergic Signalling journal cover Medicine
Back to journal directory

Review Cycle Records

Purinergic Signalling

Springer SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 42025 JCR Q3
109.1Average days
91Median days
2Fastest days
288Longest days
462025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

68 days

Soluble P2X7 receptor (sP2X7R) as a marker of inflammation in pregnancy

AuthorsValentina Vultaggio-Poma; Selene Schio; Cristina Taliento; Rosa Galasso; Simonetta Falzoni; Claudia D’Angiolillo; Sara Ghisellini; Pantaleo Greco; Francesco Di Virgilio; Anna Lisa Giuliani

Affiliations1. Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 2. Unit of Clinical Pathology, Sant’Anna University Hospital, Ferrara, Italy; 3. Unit of Obstetrics and Gynaecology, Sant’Anna University Hospital, Ferrara, Italy

Source PDF DOI Publisher page
2 days

Antagonism of P2X7 receptor function in synovial fibroblasts is a potential therapeutic manipulation in rheumatoid arthritis

AuthorsShi-Yan Zhang; Y. Tang; P. Illes

Affiliations1. International Joint Research Centre On Purinergic Signaling/School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China; 2. Rudolf Boehm Institute for Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

Source PDF DOI Publisher page
96 days

Electroacupuncture and P2X receptors: purinergic mechanisms in pain modulation

AuthorsRajaa Shaheen

Affiliations1. Department of Biological Sciences, University of East Anglia, Norwich, UK; 2. Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

Source PDF DOI Publisher page
86 days

Impact of cryopreservation on immune cell subset frequencies in human peripheral blood mononuclear cells following assessment of monoclonal antibodies to CD39 and P2X7

AuthorsLeon Koning; Ashleigh Splitt; Daniel Brungs; Martin G. Carolan; Senthilkumar Gandhidasan; Ronald Sluyter

Affiliations1. Molecular Horizons, University of Wollongong, Wollongong, Australia; 2. School of Science, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia; 3. Illawarra Cancer Care Centre, Wollongong Hospital, Wollongong, Australia; 4. Graduate School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia

Source PDF DOI Publisher page
154 days

Interaction between purinergic signalling and purinergic modulators with skin wound repair effectors: a systematic review of preclinical in vivo models

AuthorsSilvânia Mól Pelinsari; Reggiani Vilela Goncalves; Patricia da Silva Mattosinhos; Mariáurea Matias Sarandy; Emerson Ferreira Vilela; Rômulo Dias Novaes

Affiliations1. Department of General Biology, Federal University of Vicosa, Vicosa, Brazil; 2. Plants for Human Health Institute, North Carolina Research Campus, NC State University, Kannapolis, USA; 3. Departament of Animal Biology, Federal University of Viçosa, Viçosa, Brazil; 4. Fundação Percival Farquhar - UNIVALE, Núcleo da Saúde, Curso de Biomedicina, Governador Valadares, Brazil; 5. Minas Gerais Agricultural Research Agency (Epamig Sul), Experimental Field of São Sebastião Do Paraíso, São Sebastião Do Paraíso, Brazil; 6. Institute of Biomedical Sciences, Department of Structural Biology, Federal University of Alfenas, Alfenas, Brazil

Source PDF DOI Publisher page
143 days

Effects on mouse melanoma and immune cells of P2X7 receptor positive allosterism by clemastine

AuthorsMaria Luiza Thorstenberg; Simonetta Falzoni; Rocio Edith Garcia-Jacobo; Leticia Scussel Bergamin; Mario Tarantini; Giulia Conversano; Anna Pegoraro; Francesco Di Virgilio; Elena Adinolfi; Anna Lisa Giuliani

Affiliations1. Department of Medical Sciences, University of Ferrara, Ferrara, Italy

Source PDF DOI Publisher page
288 days

Differential expression, activity, and fibroblast growth factor 2-mediated modulation of purine-metabolizing enzymes in cultured cortical astrocytes and microglia

AuthorsRyota Eguchi; Ken-ichi Otsuguro

Affiliations1. Laboratory of Pharmacology, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan

Source PDF DOI Publisher page
43 days

The P2X7 receptor: insights from the murine monoclonal antibody clone L4

AuthorsRonald Sluyter; Amal Elhage; Rachael Bartlett; Debbie Watson; Leanne Stokes; Kristen K. Skarratt; Stephen J. Fuller; Ben J. Gu

Affiliations1. Molecular Horizons and School of Science, University of Wollongong, Wollongong, Australia; 2. School of Chemistry, Pharmacy & Pharmacology, University of East Anglia, Norwich, Norfolk, UK; 3. Sydney Medical School Nepean, Faculty of Medicine and Health, The University of Sydney, Nepean Hospital, Penrith, Australia; 4. Qankorey Biotechnology Co. Ltd, Changsha, China; 5. The Florey Institute, University of Melbourne, Parkville, Australia; 6. The Innate Phagocytosis Lab, Melbourne, Australia

Source PDF DOI Publisher page
39 days

Is adenosine signalling entering the precision medicine era? From receptor pharmacology to patient stratification

AuthorsLuca Antonioli; György Haskó

Affiliations1. Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2. Department of Anesthesiology, Columbia University, New York, USA

Source PDF DOI Publisher page
98 days

Inflammation, oxidative stress and purinergic signaling in pituitary neuroendocrine tumors (PitNETs)

AuthorsYenidis Teilor Scheibel; Symon Martins; André Paulo Turcatel; Francini Franscescon; Débora Tavares de Resende e Silva

Affiliations1. Medicine Department, Federal University of Fronteira Sul (UFFS), Chapecó, Brazil; 2. Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul (UFFS), Chapecó, Brazil

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.